| Filed On | Filing |
|---|---|
| 22 Sep 2023 |
8-K/A: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation
This Separation Agreement and General Release (“Agreement”) is entered into by and between Jeff Miner (Employee) and Organovo, Inc. (“Company”). The Employee’s Company employment ended on August 25, 2023 (Separation Date). The “Effective... |
| 21 Sep 2020 |
8-K/A: Submission of Matters to a Vote of Security Holders
The Company’s stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. |
| 19 Mar 2015 |
8-K/A: Departure/Election of Directors or Officers; Compensation
As previously reported, on December 8, 2014 the Company issued a press release regarding the appointment of Kirk Malloy, Ph.D., as a new Class I director of the Company. At the time of his initial appointment, Dr. Malloy was not appointe... |
| 10 Aug 2012 |
8-K/A: Departure/Election of Directors or Officers; Compensation
As previously reported, on August 6, 2012, a committee of the Board of Directors of the Company, granted RSUs under the Organovo Holdings, Inc. 2012 Equity Incentive Plan to certain executive officers, including Barry D. Michaels. Due to... |
| 11 May 2012 |
8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more
This Agreement is made and entered into by and between the Clemson University Research Foundation, a corporation duly organized and existing under the laws of South Carolina and having its principal office at 91 Technology Drive, AMRL Bu... |
| 30 Mar 2012 |
8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more
Organovo is developing a 3D Bio-printer as part of their groundbreaking process to produce tissue engineered constructs for tissue repair and organ replacement. |
Loading...